期刊文献+

细胞外信号调节激酶在卵巢肿瘤的表达 被引量:1

Expression of Extracellular Signal-regulated Kinase in Epithelial Ovarian Cancer
暂未订购
导出
摘要 [目的]探讨细胞外信号调节激酶(ERK)在卵巢上皮性肿瘤组织中的表达及其意义.[方法]应用免疫组织化学技术,检测49例卵巢上皮性癌组织、26例卵巢上皮性良性肿瘤组织及10例正常卵巢组织中ERK1/2蛋白和活性ERK1/2蛋白表达.[结果]ERK1/2在卵巢上皮性癌组织中的表达阳性率为63%,显著高于正常卵巢组织(阴性)和卵巢良性肿瘤组织(27%)(P<0.01).活性ERK1/2在卵巢上皮性癌中的阳性表达率为65%,明显高于卵巢良性肿瘤组织中的阳性表达率19%(P<0.01).Ⅲ~Ⅳ期卵巢癌组织中ERK1/2及活性ERK1/2表达水平高于Ⅰ~Ⅱ期,差异有显著性(P<0.05,P<0.01).病情进展患者活性ERK1/2表达阳性率为82%,较病情未进展者(43%),差异有显著性(P<0.01).[结论]ERK蛋白的过表达在卵巢上皮性癌患者的发生、发展中可能起重要促进作用,可判断卵巢上皮性癌的病情进展情况. [Purpose]To investigate the expression of extracellular signal-regulated kinase(ERK)and its sig-nificance in epithelial ovarian tumor.Expression of ERK1/2protein and active ERK1/2were ex-amined by immunohistochemical method in49patients with epithelial ovarian cancer,26patients with be-nign epithelial ovarian tumor and10normal ovarian tissues.The positive percentage of ERK1/2protein in ovarian cancer was63%,which was significantly higher than that in benign tumors and normal o-varian tissues(P<0.01).The positive percentage of active ERK1/2in ovarian cancer(65%)was significantly higher than that in benign tumors(19%).The positive percentages of ERK1/2protein and active ERK1/2in stageⅢ~Ⅳepithelial ovarian cancer was significantly higher than those in stageⅠ~Ⅱepithelial ovarian cancer(P<0.05,P<0.01)respectively.The positive percentage of active ERK1/2in progressive patients with epithelial ovarian cancer(82%)was significantly higher than that in patients in remission(43%,P<0.01).[Conclusions]The overexpression of ERK may play an important role in the initiation and development of human ovarian cancer,and judge the progression of epithelial ovarian cancer.
出处 《中国肿瘤》 CAS 2003年第11期682-684,共3页 China Cancer
关键词 卵巢肿瘤 细胞外信号调节激酶 免疫组织化学 ovarian neoplasms extracellular signal-regulated kinase immunohistochemistry
  • 相关文献

参考文献9

  • 1Johnson GL, Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science,2002,298:1911-1912.
  • 2Webb CP, Van Aelst L, Wigler MH, et al. Signaling pathways in Ras-mediated tumorigenicity and metastasis [J].Proc Natl Acad Sci USA,1998,95:8773-8778.
  • 3Andresen BT, Rizzo MA, Shome K, et al. The role of phosphatidic acid in the regulation of the Ras/MEK/Erk signaling cascade[J]. FEBS Lett,2002,53: 65-68.
  • 4Caroline RW,William LB,Linda SS,et al.The raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor responsive tumors[J].Pharmacol Therapeut,2000,88:229-279.
  • 5Manni A,Weehter R,Gilmour S,et al.Omithine deearboxylase overexpression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells[J]. Int J Cancer,1997,70:175-182.
  • 6LicatoLL,KekuTO,WurselmannJI,et al.In vivo association of mitogen-activated protein kinases in rat intestinal neoplasia[J].Gastroenterology,1997,113:1589-1598.
  • 7Oka H, Chatani Y, Hoshino R, et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma [J]. Cancer Research,1995,55:4182-4187.
  • 8Seidman R, Gitelman I, Sagi O, et al. The role of ERK1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells [J].Exp Cell Res,2001,268:84-92.
  • 9Thimmaiah KN,Easton J, Huang S, et al. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erkl-Erk2 and phosphatidylinositol 3'-Kinase-Akt signaling pathways[J].Cancer Res,2003,63:364-374.

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部